| Literature DB >> 33363954 |
Fanny Collette1, Marc Hamoir2, Pascal Van Eeckhout3, Philippe D'Abadie4, Thierry Duprez5, Sandra Schmitz2, Jean-Pascal Machiels1.
Abstract
Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti-androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression.Entities:
Keywords: Primary cutaneous apocrine adenocarcinoma; androgen receptor; anti‐androgen therapy; metastatic cancer; sweat glands
Year: 2020 PMID： 33363954 PMCID： PMC7752452 DOI： 10.1002/ccr3.3434
Source DB: PubMed Journal: Clin Case Rep ISSN： 2050-0904